• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者的护理质量评估:将常规护理数据转化为持续改进系统。

Quality of care assessment for non-small cell lung cancer patients: transforming routine care data into a continuous improvement system.

作者信息

Sánchez Juan C, Nuñez-García Beatriz, Garitaonaindia Yago, Calvo Virginia, Blanco Mariola, Ramos Martín-Vegue Arturo, Royuela Ana, Manso Marta, Cantos Blanca, Méndez Miriam, Collazo-Lorduy Ana, Provencio Mariano

机构信息

Medical Oncology Department, Puerta de Hierro-Majadahonda University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222, Madrid, Spain.

Admission and Clinical Documentation Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain.

出版信息

Clin Transl Oncol. 2025 Mar;27(3):1047-1061. doi: 10.1007/s12094-024-03658-3. Epub 2024 Aug 16.

DOI:10.1007/s12094-024-03658-3
PMID:39147937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11913935/
Abstract

PURPOSE

The complexity of cancer care requires planning and analysis to achieve the highest level of quality. We aim to measure the quality of care provided to patients with non-small cell lung cancer (NSCLC) using the data contained in the hospital's information systems, in order to establish a system of continuous quality improvement.

METHODS/PATIENTS: Retrospective observational cohort study conducted in a university hospital in Spain, consecutively including all patients with NSCLC treated between 2016 and 2020. A total of 34 quality indicators were selected based on a literature review and clinical practice guideline recommendations, covering care processes, timeliness, and outcomes. Applying data science methods, an analysis algorithm, based on clinical guideline recommendations, was set up to integrate activity and administrative data extracted from the Electronic Patient Record along with clinical data from a lung cancer registry.

RESULTS

Through data generated in routine practice, it has been feasible to reconstruct the therapeutic trajectory and automatically calculate quality indicators using an algorithm based on clinical practice guidelines. Process indicators revealed high adherence to guideline recommendations, and outcome indicators showed favorable survival rates compared to previous data.

CONCLUSIONS

Our study proposes a methodology to take advantage of the data contained in hospital information sources, allowing feedback and repeated measurement over time, developing a tool to understand quality metrics in accordance with evidence-based recommendations, ultimately seeking a system of continuous improvement of the quality of health care.

摘要

目的

癌症护理的复杂性需要进行规划和分析,以实现最高水平的质量。我们旨在利用医院信息系统中包含的数据来衡量为非小细胞肺癌(NSCLC)患者提供的护理质量,以便建立一个持续质量改进系统。

方法/患者:在西班牙一家大学医院进行的回顾性观察队列研究,连续纳入2016年至2020年间接受治疗的所有NSCLC患者。基于文献综述和临床实践指南建议,共选择了34个质量指标,涵盖护理流程、及时性和结果。应用数据科学方法,建立了一种基于临床指南建议的分析算法,以整合从电子病历中提取的活动和管理数据以及来自肺癌登记处的临床数据。

结果

通过常规实践中产生的数据,利用基于临床实践指南的算法重建治疗轨迹并自动计算质量指标是可行的。流程指标显示对指南建议的高度依从性,结果指标显示与先前数据相比生存率良好。

结论

我们的研究提出了一种利用医院信息源中包含的数据的方法,允许随着时间的推移进行反馈和重复测量,开发一种根据循证建议理解质量指标的工具,最终寻求一个医疗保健质量持续改进的系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/cec54c82d8c1/12094_2024_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/6683438b295e/12094_2024_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/22d33b72f415/12094_2024_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/cec54c82d8c1/12094_2024_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/6683438b295e/12094_2024_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/22d33b72f415/12094_2024_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec7/11913935/cec54c82d8c1/12094_2024_3658_Fig3_HTML.jpg

相似文献

1
Quality of care assessment for non-small cell lung cancer patients: transforming routine care data into a continuous improvement system.非小细胞肺癌患者的护理质量评估:将常规护理数据转化为持续改进系统。
Clin Transl Oncol. 2025 Mar;27(3):1047-1061. doi: 10.1007/s12094-024-03658-3. Epub 2024 Aug 16.
2
Evaluation of adherence to the Commission on Cancer lung cancer quality measures.评估对癌症委员会肺癌质量测量标准的遵守情况。
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1219-1235. doi: 10.1016/j.jtcvs.2018.09.126. Epub 2018 Nov 13.
3
Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer.与 I 期和 II 期非小细胞肺癌质量指标依从性相关的制度因素。
J Thorac Cardiovasc Surg. 2021 Sep;162(3):649-660.e8. doi: 10.1016/j.jtcvs.2020.05.123. Epub 2020 Jul 29.
4
Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator.基于分期的指南一致治疗对非小细胞肺癌生存的影响:一个新的质量指标。
Clin Lung Cancer. 2024 Dec;25(8):e466-e478. doi: 10.1016/j.cllc.2024.08.012. Epub 2024 Aug 24.
5
Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.非小细胞肺癌患者诊断与治疗质量指标的制定:迈向实施多学科、循证指南的第一步。
Lung Cancer. 2006 Oct;54(1):117-24. doi: 10.1016/j.lungcan.2006.07.001. Epub 2006 Aug 21.
6
Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer.日本转移性非小细胞肺癌患者的系统治疗模式及对指南的依从性
Future Oncol. 2025 Apr;21(9):1101-1111. doi: 10.1080/14796694.2025.2470611. Epub 2025 Feb 28.
7
Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.评价基于国家综合癌症网络指南的决策支持工具在非小细胞肺癌患者中的应用:一项非随机临床试验。
JAMA Netw Open. 2020 Sep 1;3(9):e209750. doi: 10.1001/jamanetworkopen.2020.9750.
8
INTEGRATED CARE PATHWAYS IN LUNG CANCER: A QUALITY IMPROVEMENT PROJECT.肺癌综合护理路径:一项质量改进项目。
Int J Technol Assess Health Care. 2018 Jan;34(1):3-9. doi: 10.1017/S026646231700441X. Epub 2018 Feb 6.
9
The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.指南推荐的转移性非小细胞肺癌患者治疗起始、结局和成本之间的关系。
J Manag Care Spec Pharm. 2018 Jun;24(6):554-564. doi: 10.18553/jmcp.2018.24.6.554.
10
Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry.全国范围内肺癌护理质量的提升:丹麦肺癌小组和登记处的作用。
J Thorac Oncol. 2013 Oct;8(10):1238-47. doi: 10.1097/JTO.0b013e3182a4070f.

引用本文的文献

1
Unexpected Long-Term Survival and Downstaging in Oligometastatic Non-Small Cell Lung Cancer Treated with Multimodal Therapy.多模式治疗的寡转移非小细胞肺癌患者的意外长期生存和降期
J Clin Med. 2025 May 13;14(10):3394. doi: 10.3390/jcm14103394.

本文引用的文献

1
The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach.及时性护理对肺癌生存的影响——基于人群的方法。
Ann Glob Health. 2023 Jun 5;89(1):39. doi: 10.5334/aogh.3845. eCollection 2023.
2
A data mining-based cross-industry process for predicting major bleeding in mechanical circulatory support.一种基于数据挖掘的跨行业流程,用于预测机械循环支持中的大出血。
Eur Heart J Digit Health. 2021 Oct 1;2(4):635-642. doi: 10.1093/ehjdh/ztab082. eCollection 2021 Dec.
3
Challenges to Using Big Data in Cancer.利用大数据治疗癌症面临的挑战。
Cancer Res. 2023 Apr 14;83(8):1175-1182. doi: 10.1158/0008-5472.CAN-22-1274.
4
A Systematic Review of Electronic Medical Record Driven Quality Measurement and Feedback Systems.电子病历驱动的质量测量和反馈系统的系统评价
Int J Environ Res Public Health. 2022 Dec 23;20(1):200. doi: 10.3390/ijerph20010200.
5
European Respiratory Society guideline on various aspects of quality in lung cancer care.欧洲呼吸学会关于肺癌护理质量各个方面的指南。
Eur Respir J. 2023 Feb 16;61(2). doi: 10.1183/13993003.03201-2021. Print 2023 Feb.
6
Quality measurement for cardiovascular diseases and cancer in hospital value-based healthcare: a systematic review of the literature.医院价值医疗中心血管疾病和癌症的质量测量:文献系统评价。
BMC Health Serv Res. 2022 Aug 1;22(1):979. doi: 10.1186/s12913-022-08347-x.
7
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.肺癌关键生物标志物的测定:西班牙的真实世界数据研究,具有人口统计学、临床、流行病学和病理学特征。
BMC Cancer. 2022 Jul 5;22(1):732. doi: 10.1186/s12885-022-09830-8.
8
Toward a Learning Health Care System: A Systematic Review and Evidence-Based Conceptual Framework for Implementation of Clinical Analytics in a Digital Hospital.迈向学习型医疗保健系统:数字医院中临床分析实施的系统评价与循证概念框架
Appl Clin Inform. 2022 Mar;13(2):339-354. doi: 10.1055/s-0042-1743243. Epub 2022 Apr 6.
9
Review of Cancer-Specific Quality Measures Promoting the Avoidance of Low-Value Care.癌症特异性质量措施综述,以促进避免低价值医疗。
Ann Surg Oncol. 2022 Jun;29(6):3750-3762. doi: 10.1245/s10434-021-11303-4. Epub 2022 Feb 6.
10
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group.多学科肺癌肿瘤委员会的质量指标和卓越要求:西班牙肺癌学会制定
Clin Transl Oncol. 2022 Mar;24(3):446-459. doi: 10.1007/s12094-021-02712-8. Epub 2021 Oct 19.